← Back to Analyst Consensus 
KYNB Buy
KYNTRA BIO, INC.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | Maxim Group | initiate | — → Buy | — | 42% |
| Sep 17, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| Sep 1, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jul 7, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Jun 9, 2026 | Rodman & Renshaw | initiate | — → Buy | — | 40% |
| Sep 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $43 | 44% |
| Aug 7, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $43 | 44% |
Price Target Trend
Apr 25, 2026 Oct 26, 2026
EPS Estimates
+1y —
+1q —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days